Atropine Prescribing for Myopia Control

Low-dose atropine is an effective myopia control treatment. Here's how to prescribe and monitor effectively.

Concentration Selection

0.01% Atropine

• Most commonly prescribed
• Minimal side effects
• Efficacy: 30-50%
• Good starting point

0.025% Atropine

• Moderate efficacy
• Some side effects possible
• Good balance option
• Consider for moderate progressors

0.05% Atropine

• Higher efficacy: 50-65%
• More side effects
• May need photochromic lenses
• For fast progressors

Prescribing Protocol

Initial Prescription

• Start with 0.01% typically
• One drop each eye at bedtime
• Provide patient education
• Schedule follow-up

Formulation Options

• Compounding pharmacy
• Commercial preparations (where available)
• Preservative-free preferred
• Ensure quality control

Pharmacy Considerations

• Find reliable compounder
• Verify concentration accuracy
• Discuss storage requirements
• Establish refill protocol

Patient Selection

Good Candidates

• Documented myopia progression
• Age typically 4-12 years
• Compliant family
• No contraindications

Contraindications

• Allergy to atropine
• Angle-closure risk
• Certain systemic conditions
• Non-compliant patients

Monitoring Protocol

Initial Follow-Up

• 1 month: assess tolerance
• 3 months: early efficacy
• 6 months: confirm response
• Annually: comprehensive review

Assessments

• Side effect inquiry
• Pupil size
• Near vision
• Axial length
• Refraction

Managing Side Effects

Photophobia

• Photochromic lenses
• Sunglasses outdoors
• Consider lower concentration
• Usually improves over time

Near Vision Blur

• Usually minimal at 0.01%
• Progressive addition lenses if needed
• Consider concentration reduction
• Monitor reading ability

Systemic Effects

• Rare at low doses
• Educate about signs
• Document any reports
• Discontinue if significant

Treatment Duration

How Long to Treat

• Typically until progression slows
• Often through teenage years
• Individualized decision
• Monitor for rebound

Discontinuation

• Gradual taper recommended
• Monitor closely after stopping
• Resume if progression returns
• Discuss with family

Documentation

Required Records

• Indication and rationale
• Concentration prescribed
• Pharmacy information
• Side effect monitoring
• Efficacy assessment

Informed Consent

• Off-label use discussion
• Expected benefits
• Possible side effects
• Alternative options